Chk1 Inhibition Activates P53 Through P38 MAPK in Tetraploid Cancer Cells

Cell Cycle - United States
doi 10.4161/cc.7.13.6073
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Nicotinamide N-Methyltransferase Enhances Resistance to 5-Fluorouracil in Colorectal Cancer Cells Through Inhibition of the ASK1-p38 MAPK Pathway

Oncotarget
Oncology
2016English

EGFR Family Inhibition Identifies P38 MAPK as a Potential Therapeutic Target in Bladder Cancer

Urology
Urology
2018English

Novel Roles for P53 in the Genesis and Targeting of Tetraploid Cancer Cells

PLoS ONE
Multidisciplinary
2014English

Deguelin Induces Apoptosis in Colorectal Cancer Cells by Activating the P38 MAPK Pathway

Cancer Management and Research
Oncology
2018English

Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional P53

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

P38 MAPK Regulates the WNT Inhibitor Dickkopf-1 in Osteotropic Prostate Cancer Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2016English

Moxonidine Improves Cardiac Structure and Performance in SHR Through Inhibition of Cytokines, P38 MAPK and Akt

British Journal of Pharmacology
Pharmacology
2011English

P38-Mapk Inhibition and Endotoxin Induced Tubular Dysfunction in Men

Journal of Endotoxin Research
2004English

Lipocalin 2 Inversely Regulates TRAIL Sensitivity Through P38 MAPK-mediated DR5 Regulation in Colorectal Cancer

International Journal of Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy